Get started
Live feed
·
PRReleasevia Quantisnow
CareDx Inc. logo

CareDx Announces New KOAR Data Linking Elevated AlloSure® Kidney to Nearly 3-Fold Higher Risk of Adverse Graft Outcomes in Patients with Borderline Rejection or TCMR at ASN Kidney Week 2026

ByQuantisnow·Wall Street's wire, on your screen.
CDNACareDx Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDNA (CareDx Inc.) and more on Quantisnow.